Vitamin Shoppe, Inc (VSI) Scheduled to Post Earnings on Wednesday
Vitamin Shoppe, Inc (NYSE:VSI) is set to release its earnings data before the market opens on Wednesday, August 9th. Analysts expect Vitamin Shoppe to post earnings of $0.40 per share for the quarter. Vitamin Shoppe has set its FY17 guidance at $1.50-1.75 EPS.
Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings data on Wednesday, May 10th. The specialty retailer reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.21. Vitamin Shoppe had a return on equity of 9.35% and a net margin of 1.43%. The company had revenue of $316.90 million for the quarter, compared to the consensus estimate of $325.71 million. During the same quarter in the previous year, the firm posted $0.67 EPS. The business’s revenue for the quarter was down 5.9% compared to the same quarter last year. On average, analysts expect Vitamin Shoppe to post $1.57 EPS for the current fiscal year and $1.68 EPS for the next fiscal year.
Vitamin Shoppe, Inc (NYSE:VSI) opened at 9.85 on Tuesday. The company has a market cap of $228.16 million, a P/E ratio of 12.68 and a beta of 0.68. The stock’s 50 day moving average is $11.06 and its 200 day moving average is $16.58. Vitamin Shoppe, Inc has a 12-month low of $9.75 and a 12-month high of $28.94.
A number of research firms have recently issued reports on VSI. Morgan Stanley upgraded shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 target price for the company in a research note on Thursday, May 11th. Gabelli lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. ValuEngine lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. BidaskClub lowered shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Finally, Zacks Investment Research lowered shares of Vitamin Shoppe from a “hold” rating to a “strong sell” rating in a research report on Saturday, May 13th. Two research analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The stock currently has an average rating of “Hold” and an average price target of $21.50.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.